New Zealand markets open in 38 minutes

PFE Dec 2025 27.500 call

OPR - OPR Delayed price. Currency in USD
Add to watchlist
3.0600-0.5400 (-15.00%)
As of 02:33PM EDT. Market open.
Full screen
Previous close3.6000
Open3.0900
Bid2.9500
Ask3.7000
Strike27.50
Expiry date2025-12-19
Day's range2.9900 - 3.0900
Contract rangeN/A
Volume6
Open interest5.63k
  • Reuters

    Kansas accuses Pfizer of misleading public about COVID vaccine in lawsuit

    The U.S. state of Kansas on Monday sued Pfizer, accusing the company of misleading the public about its COVID-19 vaccine by hiding risks while making false claims about its effectiveness. In a lawsuit filed in the District Court of Thomas County, the state said the New York-based drugmaker's alleged false statements violated the Kansas Consumer Protection Act. "Pfizer made multiple misleading statements to deceive the public about its vaccine at a time when Americans needed the truth," Kansas Attorney General Kris Kobach, a Republican, said in a statement.

  • Zacks

    Moderna's (MRNA) Next-Gen COVID-19 Jab Study Meets Efficacy Goal

    Data from a late-stage study shows that Moderna's (MRNA) next-generation COVID-19 vaccine achieved non-inferior vaccine efficacy against COVID-19 when compared with its previously approved bivalent COVID-19 vaccine.

  • Zacks

    Pharma Stock Roundup: FDA Panel Endorses LLY's Donanemab, PFE's DMD Therapy Study Fails

    An FDA panel endorses Eli Lilly's (LLY) Alzheimer's disease drug, donanemab. Pfizer's (PFE) DMD study on investigational gene therapy fails.